News & Media

Delhi HC stays ban on sale and manufacture of Oxytocin till October

Aug 31, 2018
  • Published by : Bar & Bench
  • Author(s) : Ashish Prasad
  • The Delhi High Court today stayed Central Government’s decision to ban the sale and manufacture of oxytocin, a peptide hormone, by private companies, till October 1.

    We are of the prima facie opinion that the domestic ban/complete prohibition on the sale and manufacturing of oxytocin should be suspended for one month. Parties may in the meantime complete their submissions. List for further arguments.”, the Court said.

    A Division Bench comprising Justices S Ravindra Bhat

    Related Articles

    News & Media

    Easing license extension for drug makers,... 22 October 2018

    In a push for greater ease of doing business in the...

    News & Media

    Big Indian deals fall short of closure 23 August 2018

    MUMBAI: Some of India Inc's biggest consolidation deals -...

    News & Media

    Sebi scanner on valuation paid under... 22 October 2018

    The Securities and Exchange Board of India (Sebi) is...

    News & Media

    Deal Reporting – Investment in Future... 23 August 2018

    Singapore-based private equity firm L Catterton Asia is...